Last reviewed · How we verify
Estradiol (E2) — Competitive Intelligence Brief
phase 3
Estrogen receptor agonist
Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ)
Endocrinology
Small molecule
Live · refreshed every 30 min
Target snapshot
Estradiol (E2) (Estradiol (E2)) — Martin Blomberg Jensen. Estradiol binds to estrogen receptors (ERα and ERβ) in target tissues to modulate gene expression and produce estrogenic effects.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Estradiol (E2) TARGET | Estradiol (E2) | Martin Blomberg Jensen | phase 3 | Estrogen receptor agonist | Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ) | |
| Vaginal estradiol tablets | Vaginal estradiol tablets | Johns Hopkins University | marketed | Estrogen receptor agonist | Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) | |
| estriol cream | estriol cream | Hatice Tukenmez Kurnaz | marketed | Estrogen receptor agonist | Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) | |
| Estradiol 0.01% Vag Cream | Estradiol 0.01% Vag Cream | TriHealth Inc. | marketed | Estrogen receptor agonist | Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) | |
| Estriol Cream 0.1% | Estriol Cream 0.1% | Dr. August Wolff GmbH & Co. KG Arzneimittel | marketed | Estrogen receptor agonist | Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) | |
| estradiol valerat | estradiol valerat | farzaneh hojjat | marketed | Estrogen receptor agonist | Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ) | |
| Generic Estradiol Vaginal Cream USP, 0.01% | Generic Estradiol Vaginal Cream USP, 0.01% | Actavis Inc. | phase 3 | Estrogen receptor agonist | Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Estrogen receptor agonist class)
- Actavis Inc. · 1 drug in this class
- Bayer · 1 drug in this class
- Dr. August Wolff GmbH & Co. KG Arzneimittel · 1 drug in this class
- Hatice Tukenmez Kurnaz · 1 drug in this class
- Johns Hopkins University · 1 drug in this class
- Martin Blomberg Jensen · 1 drug in this class
- TriHealth Inc. · 1 drug in this class
- farzaneh hojjat · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Estradiol (E2) CI watch — RSS
- Estradiol (E2) CI watch — Atom
- Estradiol (E2) CI watch — JSON
- Estradiol (E2) alone — RSS
- Whole Estrogen receptor agonist class — RSS
Cite this brief
Drug Landscape (2026). Estradiol (E2) — Competitive Intelligence Brief. https://druglandscape.com/ci/estradiol-e2. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing